| Oct 21 |
Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement
|
| Oct 21 |
Boston Scientific wins FDA approval for Farapulse cardiac mapping
|
| Oct 21 |
Boston Scientific blood-blocking agent tied to additional 2 deaths, 8 injuries
|
| Oct 19 |
Boston Scientific launches next-gen cardiac mapping for FARAPULSE
|
| Oct 18 |
Boston Sci gets FDA okay for Farapulse cardiac mapping products
|
| Oct 18 |
Needham Downgrades Boston Scientific Over Watchman Growth Concerns and Uncertain Trial Outcomes
|
| Oct 18 |
Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System
|
| Oct 18 |
Boston Scientific cut to Hold at Needham on growth concerns
|
| Oct 18 |
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
|
| Oct 18 |
Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
